WS5, a direct target of oncogenic transcription factor Myc, is related to human melanoma glycoprotein genes and has oncogenic potential

Oncogene

Volumn 26, Issue 12, 2007, Pages 1769-1779

  Reiter, F ^a   Hartl, M ^a   Karagiannidis, A I ^a   Bister, K ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

C EBP; Cell transformation; Gene expression; GPNMB; Pmel17

Indexed keywords

AMINO ACID; CARCINOGEN; CCAAT ENHANCER BINDING PROTEIN ALPHA; GLYCOPROTEIN; MAX PROTEIN; MELANOMA ANTIGEN; MEMBRANE PROTEIN; MESSENGER RNA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MYC PROTEIN; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; ARTICLE; AVIAN LEUKOSIS ONCOVIRUS; BINDING SITE; BRAIN TUMOR; CANCER CELL CULTURE; CELL TRANSFORMATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA BINDING; EXON; FIBROBLAST; FOWL; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE ISOLATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KIDNEY POLYCYSTIC DISEASE; LIVER TUMOR; MELANOMA; MELANOMA CELL; METASTASIS; NUCLEOTIDE SEQUENCE; ONCOGENE MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; TUMOR GENE; TUMOR GROWTH;

AMINO ACID SEQUENCE; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GLYCOPROTEINS; HUMANS; MELANOMA; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; SEQUENCE HOMOLOGY, AMINO ACID;

ALPHARETROVIRUS; AVES; MAMMALIA;

EID: 33947257902     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209975     Document Type: Article

References (47)

1. Adhikary S, Eilers M. (2005). Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6: 635-645.
2. Bader AG, Hartl M, Bister K. (2000). Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun allele. Virology 270: 98-110.
3. Ben-Porath I, Yanuka O, Benvenisty N. (1999). The Tmp gene, encoding a membrane protein, is a c-Myc target with a tumorigenic activity. Mol Cell Biol 19: 3529-3539.
4. Berson JF, Harper DC, Tenza D, Raposo G, Marks MS. (2001). Pmel17 initiates premelanosome morphogenesis within multivesicular bodies. Mol Biol Cell 12: 3451-3464.
5. Berson JF, Theos AC, Harper DC, Tenza D, Raposo G, Marks MS. (2003). Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis. J Cell Biol 161: 521-533.
6. Bister K, Hayman MJ, Vogt PK. (1977). Defectiveness of avian myelocytomatosis virus MC29: isolation of long-term nonproducer cultures and analysis of virus-specific polypeptide synthesis. Virology 82: 431-448.
7. Bister K, Jansen HW. (1986). Oncogenes in retroviruses and cells: biochemistry and molecular genetics. Adv Cancer Res 47: 99-188.
8. Blackwell TK, Huang J, Ma A, Kretzner L, Alt FW, Eisenman RN et al. (1993). Binding of Myc proteins to canonical and noncanonical DNA sequences. Mol Cell Biol 13: 5216-5224.
9. Bycroft M, Bateman A, Clarke J, Hamill SJ, Sandford R, Thomas RL et al. (1999). The structure of a PKD domain from polycystin-1: implications for polycystic kidney disease. EMBO J 18: 297-305.
10. Clark LA, Wahl JM, Rees CA, Murphy KE. (2006). Retrotransposon insertion in SILV is responsible for merle patterning of the domestic dog. Proc Natl Acad Sci USA 103: 1376-1381.
11. Dang CV. (1999). c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19: 1-11.
12. Du J, Miller AJ, Widlund HR, Horstmann MA, Ramaswamy S, Fisher DE. (2003). MLANA/MART1 and SILV/PMEL17/ GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Am J Pathol 163: 333-343.
13. Eisenman RN. (2001). Deconstructing Myc. Genes Dev 15: 2023-2030.
14. Ferré-D'Amaré AR, Prendergast GC, Ziff EB, Burley SK. (1993). Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain. Nature 363: 38-46.
15. Fieber W, Schneider ML, Matt T, Kräutler B, Konrat R, Bister K. (2001). Structure, function, and dynamics of the dimerization and DNA binding domain of oncogenic transcription factor v-Myc. J Mol Biol 307: 1395-1410.
16. Grabe N. (2002). AliBaba2: context specific identification of transcription factor binding sites. In Silico Biol 2: S1-15.
17. Grandori C, Cowley SM, James LP, Eisenman RN. (2000). The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 16: 653-699.
18. Hartl M, Bister K. (1995). Specific activation in jun-transformed avian fibroblasts of a gene (bkj) related to the avian β-keratin gene family. Proc Natl Acad Sci USA 92: 11731-11735.
19. Hartl M, Bister K. (1998). Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation. Oncogene 17: 2901-2913.
20. Hartl M, Karagiannidis AI, Bister K. (2006). Cooperative cell transformation by Myc/Mil(Raf) involves induction of AP-1 and activation of genes implicated in cell motility and metastasis. Oncogene 25: 4043-4055.
21. Hartl M, Matt T, Schüler W, Siemeister G, Kontaxis G, Kloiber K et al. (2003). Cell transformation by the v-myc oncogene abrogates c-Myc/Max-mediated suppression of a C/EBPβ-dependent lipocalin gene. J Mol Biol 333: 33-46.
22. Hartl M, Reiter F, Bader AG, Castellazzi M, Bister K. (2001). JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesis. Proc Natl Acad Sci USA 98: 13601-13606.
23. Heckman CA, Wheeler MA, Boxer LM. (2003). Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells. Oncogene 22: 7891-7899.
24. Hermeking H, Rago C, Schuhmacher M, Li Q, Barrett JF, Obaya AJ et al. (2000). Identification of CDK4 as a target of c-MYC. Proc Natl Acad Sci USA 97: 2229-2234.
25. Jing H, Takagi J, Liu JH, Lindgren S, Zhang RG, Joachimiak A et al. (2002). Archaeal surface layer proteins contain β propeller, PKD, and β helix domains and are related to metazoan cell surface proteins. Structure 10: 1453-1464.
26. Kato GJ, Dang CV. (1992). Function of the c-Myc oncoprotein. FASEB J 6: 3065-3072.
27. Kwon BS, Chintamaneni C, Kozak CA, Copeland NG, Gilbert DJ, Jenkins N et al. (1991). A melanocyte-specific gene, Pmel 17, maps near the silver coat color locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12. Proc Natl Acad Sci USA 88: 9228-9232.
28. Levens DL. (2003). Reconstructing MYC. Genes Dev 17: 1071-1077.
29. Liu YN, Kang BB, Chen JH. (2004). Transcriptional regulation of human osteopontin promoter by C/EBPα and AML-1 in metastatic cancer cells. Oncogene 23: 278-288.
30. Matys V, Fricke E, Geffers R, Gößling E, Haubrock M, Hehl R et al. (2003). TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 31: 374-378.
31. Menssen A, Hermeking H. (2002). Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc Natl Acad Sci USA 99: 6274-6279.
32. Mink S, Mutschler B, Weiskirchen R, Bister K, Klempnauer KH. (1996). A novel function for Myc: inhibition of C/EBP-dependent gene activation. Proc Natl Acad Sci USA 93: 6635-6640.
33. Mink S, Jaswal S, Burk O, Klempnauer KH. (1999). The v-Myb oncoprotein activates C/EBPβ expression by stimulating an autoregulatory loop at the C/EBPβ promoter. Biochim Biophys Acta 1447: 175-184.
34. Mochii M, Agata K, Eguchi G. (1991). Complete sequence and expression of a cDNA encoding a chicken 115-kDa melanosomal matrix protein. Pigment Cell Res 4: 41-47.
35. Nair SK, Burley SK. (2003). X-ray structures of Myc-Max and Mad-Max recognizing DNA: molecular bases of regulation by proto-oncogenic transcription factors. Cell 112: 193-205.
36. Neiman PE, Ruddell A, Jasoni C, Loring G., Thomas SJ, Brandvold KA et al. (2001). Analysis of gene expression during myc oncogene-induced lymphomagenesis in the bursa of Fabricius. Proc Natl Acad Sci USA 98: 6378-6383.
37. Nesbit CE, Tersak JM, Prochownik EV. (1999). MYC oncogenes and human neoplastic disease. Oncogene 18: 3004-3016.
38. Oberst C, Hartl M, Weiskirchen R, Bister K. (1999). Conditional cell transformation by doxycycline-controlled expression of the MC29 v-myc allele. Virology 253: 193-207.
39. O'Donnell KA, Yu D, Zeller KI, Kim JW, Racke F, Thomas-Tikhonenko A et al. (2006). Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol Cell Biol 26: 2373-2386.
40. Patel JH, Loboda AP, Showe MK, Showe LC, McMahon SB. (2004). Analysis of genomic targets reveals complex functions of MYC. Nat Rev Cancer 4: 562-568.
41. Rich JN, Shi Q, Hjelmeland M, Cummings TJ, Kuan CT, Bigner DD et al. (2003). Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J Biol Chem 278: 15951-15957.
42. Secombe J, Pierce SB, Eisenman RN. (2004). Myc: A weapon of mass destruction. Cell 117: 153-156.
43. Theos AC, Truschel ST, Raposo G, Marks MS. (2005). The Silver locus product Pmel17/gp100/Silv/ME20: controversial in name and in function. Pigment Cell Res 18: 322-336.
44. Turque N, Denhez F, Martin P, Planque N, Bailly M, Bègue A et al. (1996). Characterization of a new melanocyte-specific gene (QNR-71) expressed in v-myc-transformed quail neuroretina. EMBO J 15: 3338-3350.
45. Wang GL, Timchenko NA. (2005). Dephosphorylated C/EBPα accelerates cell proliferation through sequestering retinoblastoma protein. Mol Cell Biol 25: 1325-1338.
46. Weterman MA, Ajubi N, van Dinter IM, Degen WG, van Muijen GN, Ruitter DJ et al. (1995). Nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts. Int J Cancer 60: 73-81.
47. Zhang XY, DeSalle LM, Patel JH, Capobianco AJ, Yu D, Thomas-Tikhonenko A et al. (2005). Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proc Natl Acad Sci USA 102: 13968-13973.